SUMMARY The uptake of Tc-99m pertechnetate and Co-57 bleomycin and the ultrastructure of small blood vessels were studied in 10 cases of meningioma. When thin sections of 120 contact areas between adjacent endothelial cells were examined, 920() of the intercellular contacts contained one to three punctate tight junctions. Freeze fracture preparations revealed fascia occludens with one to four sealing strands. These findings are consistent with the high permeability the meningiomas displayed for both of the radiopharmaceuticals.
The normal brain capillaries, having a "blood barrier", are not permeable to appreciable amounts of radiopharmaceuticals, contrast materials, and many other substances. The ultrastructural basis for this barrier1 2 is the presence of belts of tight junctions between the endothelial cells. Also, normal blood capillaries are non-fenestrated and have very few pinocytic vesicles. The vessels of tumour are different from those of the normal brain. Their increased permeability permits the visualisation of these tumours by radionuclide imaging and computed tomography and the penetration of chemotherapeutic agents from the blood. In a previous preliminary study3 we compared the ultrastructure of tumour vessels with the in vivo Tc-99m pertechnetate uptake. In the present study a group of highly permeable tumours, meningiomas,4 was selected in order to study in depth the ultrastructural nature of the intercellular contacts. These were correlated with tumour uptake of Tc-99m, a common scintigraphic agent and Co-57 bleomycin, a labelled chemotherapeutic drug. Submitted 22 June 1981 Accepted 6 August 1981 in this study. Routine brain scintigrams were done with Tc-99m pertechnetate.3 Co-57 bleomycin with a specificity of lmCi Co-57/mg bleomycin was prepared from chloride (Amersham Arlington) and bleomycin (BristolMyers Co, Syracuse, NY), using a technique described previously.5 6 One mCi of Co-57 bleomycin was injected intravenously and the head of the patient was imaged at 30 s after the injection and at 2 h, in the anterior and both lateral views. Data was collected with an Anger type camera for 10 min in each view. Eight patients were investigated by using both pertechnetate and labelled bleomycin, and two patients only with pertechnetate.
The meningiomas obtained at surgery were prepared for electron microscopy as previously described.3 Freeze fracture replicas were made using the methods described by Moor et . -..,---. In freeze fracture preparations variations were seen in the number, size and degree of the junctional elements. Tight junctions appeared mostly as "fascia occludens" and were composed of one to four sealing strands (fig 6a) . In only a few replicas five to six strands were seen and most areas contained only one junctional strand. There was some anastomosing of parallel strands (fig 7) , but most fibrils were not anastomosed and contained discontinuous arrays of particles.
Discussion
All the meningiomas examined showed early and markedly increased uptake of Tc-99m pertechnetate (molecule with a volume of 40A3) and Co-57 bleomycin (molecule with a diameter of 30 to 40A) indicating increased permeability to these agents. Previously, the typical feature of the meningioma capillaries was considered to be the absence of tight junctions between adjacent endothelial cells.9 This correlated well with scintigraphic findings.3 Our observations of the thin sections and the use of freeze fracture techniques indicated the presence of tight junctions which is still consistent with very high permeability. In 90 % of the appositional areas there was at least one short fusion site between the adjacent cells. In freeze fracture replicas the tight junctions appeared as "fascia occludens" and were composed of one to four sealing strands.
Several studies'0-12 correlated the freeze etch morphology of tight junctions between epithelial cells and their permeability as determined by electrical resistance measurements. Junctions with one to two sealing strands were considered as "very leaky" and those with one to six strands with depth of 0-1 to 0-08 lum in the apical basal direction were considered as "'leaky" junctions. Using these criteria, the junctions between the endothelial cells of meningioma capillaries observed in our study can be defined as both leaky and very leaky. The appearance of the tight junctions as fascia occludens may explain our previous observations3 of entirely open routes between the endothelial cells observed in thin sections. This may have been caused by a sectioning plane through a zone devoid of sealing strands. The fine structure of the junctional elements between the endothelial cells showed some special properties. Although they were discontinuous strands of random distribution similar to the structure of leaky venules in muscle, they had arrays of many protruding particles, like the structure of capillaries described in muscle with stronger cell to cell interaction. [13] [14] [15] It should be mentioned that although the vessels of the meningiomas studied also showed fenestration which may be associated with increased permeability, previous studies3 and our unpublished data show increased permeability to both pertechnetate and Co-57 bleomycin in non-fenestrated vessels. The role of pinocytic vesicles remains to be clarified.
It may be concluded that thin section findings of at least one fusion site between adjacent endothelial cell membrane in more than 90O% of the intercellular boundaries with the laminal-basal axis of 0 1 to 0-8 ,um and freeze fracture preparations with tight junctions appearing as fascia occludens composed of one to four sealing strands are compatible with high permeability both to Tc-99m pertechnetate and Co-57 bleomycin. Such findings in brain tumours other than meningiomas may indicate that their vessels are permeable to chemotherapeutic drugs with diameter smaller than 40 A. It has been suggested that in the chemotherapy of brain tumours, the blood brain barrier is not a factor.'6 The present study defines further the ultrastructural characteristics of vessel permeability in brain tumours. 
